Monday, June 19, 2023
Orthofix, a leading global spine and orthopedics company, has announced the full commercial launch of the WaveForm® A interbody for Anterior Lumbar Interbody Fusion (ALIF) procedures. This interbody device seamlessly integrates with Orthofix's Meridian ALIF system, providing a solution for fusion in patients with degenerative disc disease. The WaveForm A interbody has a unique wave-like design that offers a balance of strength, porosity, and stability. It features a large implant graft aperture to facilitate the use of bone graft material, creating an optimal environment for supplemental fixation procedures.
According to Dr. Neil Arif Tayyab, an orthopaedic spine surgeon, the design and surface technology of implants play a vital role in bone growth during fusion. The WaveForm A interbody, with its innovative design, can stimulate better bone growth responses and increase the chances of successful fusion.
The Meridian ALIF system is a modular instrument and implant system that works with both the WaveForm A interbody and Orthofix's Reef™ A interbody, which utilizes NanoMetalene® surface technology and Reef Topography™. With the launch of the WaveForm A, the Meridian system can effectively cater to the ALIF market segment in the U.S.
The WaveForm A implants are 3D printed and utilize WaveForm® technology, characterized by a repeating wave-like structure. This design provides strength while allowing for optimal endplate porosity, bone packing, decreased stiffness, and enhanced imaging properties.
Kevin Kenny, President of Global Spine at Orthofix, highlights the integration of advanced technologies in the Meridian ALIF system, simplifying procedures for surgeons. The WaveForm A interbody expands their portfolio and offers a streamlined option for ALIF procedures.
The ALIF market can be categorized based on different materials, such as non-3D printed metal, PEEK (including advanced surface technologies), 3D printed metal, and machined bone. The growth of 3D printed and advanced surface technologies-based interbody devices is expected to outpace the overall interbody market, potentially surpassing standard PEEK devices in market share.
Source: businesswire.com
